Search Results - "Calero, A."

Bioactivity and antibacterial properties of calcium- and silver-doped coatings on 3D printed titanium scaffolds by Rodríguez-Contreras, Alejandra, Torres, Diego, Rafik, Belal, Ortiz-Hernandez, Monica, Ginebra, Maria Pau, Calero, José A., Manero, José María, Ruperez, Elisa

“…One of the major problems faced by metallic implants is the high probability of bacterial infections, with significant consequences for the patient. In this…”
Get full text

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis by Voss, Oliver H., Arango, Daniel, Tossey, Justin C., Villalona Calero, Miguel A., Doseff, Andrea I.

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selective killing of cancer cells underlines its anticancer potential. However, poor…”
Get full text

Home-Based Trimodal Prehabilitation in Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery: Effect on Functional Walking Capacity and Skeletal Muscle Mass by Lario-Perez, S., Macia, J.-J., Lillo-Garcia, C., Caravaca, I., Lopez-Rodriguez, F., Calero, A., Tomas-Rodriguez, M. I., Moya-Martinez, A., Arroyo, A., Lacueva, F.-J.

“…Background Patients with peritoneal carcinomatosis often suffer from loss of skeletal muscle mass and require extensive surgery. Multimodal prehabilitation may…”
Get full text

Type of TP53 mutation influences oncogenic potential and spectrum of associated K‐ras mutations in lung‐specific transgenic mice by Duan, Wenrui, Gao, Li, Kalvala, Arjun, Aguila, Brittany, Brooks, Christopher, Mo, Xiaokui, Ding, Haiming, Shilo, Konstantin, Otterson, Gregory A., Villalona‐Calero, Miguel A.

“…TP53 and K‐ras mutations are two of the major genetic alterations in human nonsmall cell lung cancers. The association between these two genes during lung…”
Get full text

Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers by BEKAII-SAAB, Tanios, PHELPS, Mitch A, VASKO, Vasily V, BLOOMSTON, Mark, MARSH, William, AUSTIN DOYLE, L, ELLISON, Gilian, GREVER, Michael, RINGEL, Matthew D, VILLALONA-CALERO, Miguel A, XIAOBAI LI, SAJI, Motoyasu, GOFF, Laura, WOOK KAUH, John Sae, O'NEIL, Bert H, BALSOM, Stephanie, BALINT, Catherine, LIERSEMANN, Ryan

“…Biliary cancers (BCs) carry a poor prognosis, but targeting the RAS/RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK)…”
Get full text

ASO Visual Abstract: Home-Based Trimodal Prehabilitation in Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery: Effect on Functional Walking Capacity and Skeletal Muscle Mass by Lario-Perez, S., Macia, J. J., Lillo-Garcia, C., Caravaca, I., Lopez-Rodriguez, F., Calero, A., Tomas-Rodriguez, M. I., Moya-Martinez, A., Arroyo, A., Lacueva, F. -J.

Get full text

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial by JÄNNE, Pasi A, XIAOFEI WANG, VOKES, Everett E, MILLER, Vincent A, SOCINSKI, Mark A, CRAWFORD, Jeffrey, STINCHCOMBE, Thomas E, LIN GU, CAPELLETTI, Marzia, EDELMAN, Martin J, VILLALONA-CALERO, Miguel A, KRATZKE, Robert

“…Erlotinib is clinically effective in patients with non-small-cell lung cancer (NSCLC) who have adenocarcinoma, are never or limited former smokers, or have…”
Get full text

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma by Noonan, Anne M, Farren, Matthew R, Geyer, Susan M, Huang, Ying, Tahiri, Sanaa, Ahn, Daniel, Mikhail, Sameh, Ciombor, Kristen K, Pant, Shubham, Aparo, Santiago, Sexton, Jennifer, Marshall, John L, Mace, Thomas A, Wu, Christina S, El-Rayes, Bassel, Timmers, Cynthia D, Zwiebel, James, Lesinski, Gregory B, Villalona-Calero, Miguel A, Bekaii-Saab, Tanios S

“…Pelareorep causes oncolysis in tumor cells with activated Ras. We hypothesized that pelareorep would have efficacy and immunomodulatory activity in metastatic…”
Get full text

A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes by Giudici, N., Schoch, A., Genitsch, V., Rodriguez-Calero, A., Thalmann, G.N., Seiler, R.

“…•After pathological review variant histology is present in a third of UTUC.•Variant histology in UTUC as a high rate of concomitant CIS (71%).•Presence of…”
Get full text

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer by Lam, Elaine T, Ringel, Matthew D, Kloos, Richard T, Prior, Thomas W, Knopp, Michael V, Liang, Jiachao, Sammet, Steffen, Hall, Nathan C, Wakely, Jr, Paul E, Vasko, Vasyl V, Saji, Motoyasu, Snyder, Pamela J, Wei, Lai, Arbogast, Daria, Collamore, Minden, Wright, John J, Moley, Jeffrey F, Villalona-Calero, Miguel A, Shah, Manisha H

“…Mutations in the RET proto-oncogene and vascular endothelial growth factor receptor (VEGFR) activity are critical in the pathogenesis of medullary thyroid…”
Get full text

Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS‐activated tumors by Villalona‐Calero, Miguel A., Lam, Elaine, Otterson, Gregory A., Zhao, Weiqiang, Timmons, Matthew, Subramaniam, Deepa, Hade, Erinn M., Gill, George M., Coffey, Matthew, Selvaggi, Giovanni, Bertino, Erin, Chao, Bo, Knopp, Michael V.

“…BACKGROUND The type 3 Dearing reovirus (Reolysin) is a naturally occurring virus that preferentially infects and causes oncolysis in tumor cells with a…”
Get full text

EML4‐ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors by Vargas‐Madueno, Fernando, Gould, Edwin, Valor, Raul, Ngo, Nhu, Zhang, Linsheng, Villalona‐Calero, Miguel A.

“…With the advent of precision medicine, medical oncology is undergoing a transcendental change. These molecular studies have allowed us to learn about potential…”
Get full text

Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain by Fernández-de-Las-Peñas, César, Nijs, Jo, Cagnie, Barbara, Gerwin, Robert D, Plaza-Manzano, Gustavo, Valera-Calero, Juan A, Arendt-Nielsen, Lars

“…Myofascial pain syndrome is featured by the presence of myofascial trigger points (TrPs). Whether TrPs are primary or secondary phenomena or if they relate to…”
Get full text

Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants by Uberos, J., Aguilera-Rodríguez, E., Jerez-Calero, A., Molina-Oya, M., Molina-Carballo, A., Narbona-López, E.

“…The aim of the study was to determine whether routine probiotic supplementation (RPS) with Lactobacillus rhamnosus GG (LGG) or Lactobacillus acidophilus…”
Get full text

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity by Xu, Y., Villalona-Calero, M. A.

“…Camptothecins are broad-spectrum anticancer drugs that specifically target DNA topoisomerase I (Topo I). The formation of a cleavable drug–Topo I–DNA complex…”
Get full text

The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models by Ramelow, Julian, Brooks, Christopher D, Gao, Li, Almiman, Abeer A, Williams, Terence M, Villalona-Calero, Miguel A, Duan, Wenrui

“…Lung cancer is the number one cancer killer worldwide. A major drawback in the lung cancer treatment field is the lack of realistic mouse models that replicate…”
Get full text

Race and Ethnicity in Cancer Therapy: What Have We Learned? by Grenade, C, Phelps, M A, Villalona-Calero, M A

“…Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these…”
Get full text

Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer by Chu, B. F., Karpenko, M. J., Liu, Z., Aimiuwu, J., Villalona-Calero, M. A., Chan, K. K., Grever, M. R., Otterson, G. A.

“…Purpose Non-small-cell lung cancer (NSCLC) accounts for the majority of lung cancer and is the most common cause of cancer death in industrialized countries…”
Get full text

MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers by Duan, Wenrui, Tang, Shirley, Gao, Li, Dotts, Kathleen, Fink, Andrew, Kalvala, Arjun, Aguila, Brittany, Wang, Qi-En, Villalona-Calero, Miguel A.

“…The Fanconi Anemia (FA) pathway is essential for human cells to maintain genomic integrity following DNA damage. This pathway is involved in repairing damaged…”
Get full text

Optimized Design and Implementation of Digital Lock-In for Planetary Exploration Sensors by Ramirez Barcenas, A., Paz Herrera, R., Miranda Calero, J.A., Canabal Benito, M.F., Garcia Ares, E., Russu, A., Cortes, F.C., De Castro, A.J., Lopez, F., Portela-Garcia, M., Lopez Ongil, C.

“…Exploring life conditions on the near-Earth planets and satellites before carrying out human missions is an important task for Space Agencies. For that…”
Get full text